Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy-Reference-Cited by-同舟云学术

Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy

Published:2016 Issue:6 Volume:19 Page:352-363
ISSN:1662-4246
Container-title:Public Health Genomics
language:en
Short-container-title:Public Health Genomics

Author:

Vozikis Athanassios,Cooper David N.,Mitropoulou Christina,Kambouris Manousos E.,Brand Angela,Dolzan Vita,Fortina Paolo,Innocenti Federico,Lee Ming Ta Michael,Leyens Lada,Macek Jr Milan,Al-Mulla Fahd,Prainsack Barbara,Squassina Alessio,Taruscio Domenica,van Schaik Ron H.,Vayena Effy,Williams Marc S.,Patrinos George P.

Publisher

S. Karger AG

Subject

Genetics(clinical),Public Health, Environmental and Occupational Health

Reference26 articles.

1. The business value and cost–effectiveness of genomic medicine

2. The microeconomics of personalized medicine: today's challenge and tomorrow's promise

3. Stakeholder Analysis in Pharmacogenomics and Genomic Medicine in Greece

4. A critical view of the general public’s awareness and physicians’ opinion of the trends and potential pitfalls of genetic testing in Greece

5. Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Modernisation of Newborn Screening as a Pan-European Challenge – An International Delphi Study;Health Policy;2024-09

2. Paving the path for implementation of clinical genomic sequencing globally: Are we ready?;Health Affairs Scholar;2024-04-29

3. Challenges in public policy for the implementation of pharmacogenetic tests in Europe;BioSocieties;2024-03-16

4. Next-generation sequencing in pharmacogenomics – fit for clinical decision support?;Expert Review of Clinical Pharmacology;2024-01-23

5. RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers;International Journal of Molecular Sciences;2023-06-13